Should We Be Screening for SARS-CoV-2 in IBD Patients before Initiation of Biologic Therapy?
| dc.contributor.author | Hashash, Jana G. | |
| dc.contributor.author | Jabak, Suha J. | |
| dc.contributor.author | Francis, Fadi F. | |
| dc.contributor.author | Regueiro, Miguel D. | |
| dc.contributor.department | Internal Medicine | |
| dc.contributor.department | Division of Gastroenterology and Hepatology | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:43:08Z | |
| dc.date.available | 2025-01-24T11:43:08Z | |
| dc.date.issued | 2021 | |
| dc.identifier.doi | https://doi.org/10.1093/ibd/izaa173 | |
| dc.identifier.eid | 2-s2.0-85100125244 | |
| dc.identifier.pmid | 32619000 | |
| dc.identifier.uri | http://hdl.handle.net/10938/30211 | |
| dc.language.iso | en | |
| dc.publisher | Oxford University Press | |
| dc.relation.ispartof | Inflammatory Bowel Diseases | |
| dc.source | Scopus | |
| dc.subject | Biological therapy | |
| dc.subject | Covid-19 | |
| dc.subject | Ibd | |
| dc.subject | Sars-cov-2 | |
| dc.subject | Covid-19 testing | |
| dc.subject | Humans | |
| dc.subject | Inflammatory bowel diseases | |
| dc.subject | Azathioprine | |
| dc.subject | Budesonide | |
| dc.subject | Corticosteroid | |
| dc.subject | Methotrexate | |
| dc.subject | Prednisone | |
| dc.subject | Tofacitinib | |
| dc.subject | Tumor necrosis factor inhibitor | |
| dc.subject | Ustekinumab | |
| dc.subject | Clinical practice | |
| dc.subject | Coronavirus disease 2019 | |
| dc.subject | Enzyme linked immunosorbent assay | |
| dc.subject | High risk patient | |
| dc.subject | Human | |
| dc.subject | Humoral immunity | |
| dc.subject | Infection risk | |
| dc.subject | Inflammatory bowel disease | |
| dc.subject | Lung lavage | |
| dc.subject | Nonhuman | |
| dc.subject | Outcome assessment | |
| dc.subject | Personalized medicine | |
| dc.subject | Practice guideline | |
| dc.subject | Reverse transcription polymerase chain reaction | |
| dc.subject | Review | |
| dc.subject | Screening test | |
| dc.subject | Sensitivity analysis | |
| dc.subject | Severe acute respiratory syndrome coronavirus 2 | |
| dc.subject | Viral clearance | |
| dc.subject | Virus gene | |
| dc.subject | Virus shedding | |
| dc.subject | Adverse event | |
| dc.subject | Diagnosis | |
| dc.subject | Procedures | |
| dc.subject | Virology | |
| dc.title | Should We Be Screening for SARS-CoV-2 in IBD Patients before Initiation of Biologic Therapy? | |
| dc.type | Review |
Files
Original bundle
1 - 1 of 1